Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 4, 2011 - Issue
Submit an article Journal homepage
96
Views
1
CrossRef citations to date
0
Altmetric
Short Report

Exenatide improves glucocorticoid-induced glucose intolerance in mice

Ruiying Zhao1 Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA;2 Program in Genes and Development
,
Enrique Fuentes-Mattei1 Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA;2 Program in Genes and Development
,
Guermarie Velazquez-Torres1 Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA;3 Program in Cancer Biology, Graduate School of Biomedical Sciences, University of Texas Health Science Center in Houston, Houston, TX, USA
,
Chun-Hui Su1 Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA;2 Program in Genes and Development
,
Jian Chen1 Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Mong-Hong Lee1 Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA;2 Program in Genes and Development
&
Sai-Ching Jim Yeung4 Department of Endocrine Neoplasia and Hormonal Disorders;5 Department of Emergency Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
 show all
Pages 61-65 | Published online: 26 Jan 2011

References

  • Van Raalte DH Ouwens DM Diamant M Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 2009 39 81 93 19200161
  • Weiser MA Cabanillas ME Konopleva M Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen Cancer 2004 100 1179 1185 15022284
  • Hoogwerf B Danese RD Drug selection and the management of corticosteroid-related diabetes mellitus Rheum Dis Clin North Am 1999 25 489 505 10467625
  • Willi SM Kennedy A Brant BP Wallace P Rogers NL Garvey WT Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes Diabetes Res Clin Pract 2002 58 87 96 12213349
  • Clore JN Thurby-Hay L Glucocorticoid-induced hyperglycemia Endocr Pract 2009 15 469 474 19454391
  • Feng YH Velazquez-Torres G Gully C Chen J Lee MH Yeung SC The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth J Cell Mol Med 2010 5 3 [Epub ahead of print].
  • Linnebjerg H Park S Kothare PA Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes Regul Pept 2008 151 1–3 123 129 18675854
  • Ranta F Avram D Berchtold S Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4 Diabetes 2006 55 1380 1390 16644695
  • Hansen KB Vilsboll T Bagger JI Holst JJ Knop FK Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects J Clin Endocrinol Metab 2010 95 3309 3317 20410219
  • Van Raalte DH van Genugten RE Linssen MML Ouwens MDM Diamant M The glucagon-like peptide receptor agonist exenatide protects against glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans Diabetes 2010 59 Suppl 1 A62

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.